High uptake of HIV testing in a cohort of male injection drug users in Delhi, India: Prevalence and correlates of HIV infection

AIDS and Behavior

Volumn 17, Issue 7, 2013, Pages 2479-2489

  Sarna, Avina ^a   Tun, Waimar ^b   Sharma, Vartika ^c   Sebastian, Mary ^c   Madan, Ira ^d   Yadav, Amita ^c   Sheehy, Meredith ^e   Lewis, Dean ^d   Thior, Ibou ^f  

^a India Habitat Centre   (India)

^b POPULATION COUNCIL   (United States)

^c POPULATION COUNCIL   (India)

^d Sahara Centre for Residential Care and Rehabilitation   (India)

^e NOT AVAILABLE   (United States)

^f PATH   (United States)

Author keywords

Harm reduction; HIV; Injection drug user; Sexual behavior; Unsafe injection practices

Indexed keywords

ADULT; ARTICLE; COHORT ANALYSIS; DEVELOPING COUNTRY; DISEASE TRANSMISSION; HARM REDUCTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDIA; LONGITUDINAL STUDY; MALE; PATIENT ATTITUDE; RISK FACTOR; SERODIAGNOSIS; STATISTICS; SUBSTANCE ABUSE; UNSAFE SEX; UTILIZATION REVIEW; COMPLICATION; HIV INFECTIONS; PREVENTION AND CONTROL; STATISTICS AND NUMERICAL DATA; TRANSMISSION; UTILIZATION;

ADULT; AIDS SERODIAGNOSIS; COHORT STUDIES; DEVELOPING COUNTRIES; HARM REDUCTION; HIV INFECTIONS; HUMANS; INDIA; LONGITUDINAL STUDIES; MALE; PATIENT ACCEPTANCE OF HEALTH CARE; RISK FACTORS; SUBSTANCE ABUSE, INTRAVENOUS; UNSAFE SEX; UTILIZATION REVIEW;

EID: 84882730832     PISSN: 10907165     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10461-013-0442-z     Document Type: Article

References (37)

1. NACO. Annual Report. Department of AIDS Control, Ministry of Health and Family Welfare, 2009-2010.
2. NACO. National AIDS Control Programme Phase III: State Fact Sheets. Report No. http://www.nacoonline.org/upload/IEC%20Division/ Parliamentarian%20Forum%204-5%20july%202011/NACO%20Fact%20Sheet.pdf (2011). Accessed 8 Sept 2012.
3. Sarna A, Tun W, Bhattacharya A, Lewis D, Singh Y, Apicella L. Assessment of unsafe injection practices and sexual risk behaviors among male injecting drug users in two urban cities of India using respondent driven sampling. Southeast Asian J Trop Med Hyg. 2012;43(3):652-67.
4. Mahanta J, Medhi G, Paranjpe R, Roy N, Kohli A, Akojiam B, et al. Injecting and sexual risk behaviours, sexually transmitted infections and HIV prevalence in injecting drug users in three states in India. AIDS. 2008;22(Supplement 5):S59-68.
5. Panda S, Kumar M, Lokabiraman S, Jayashree K, Satagopan M, Solomon S, et al. Risk factors for HIV infection in injection drug users and evidence for onward transmission of HIV to their sexual partners in Chennai, India. J Acquir Immune Defic Syndr. 2005;39(1):9-15.
6. Panda S, Chatterjee A, Bhattacharya SK, Manna B, Singh PN, Sarkar S, et al. Transmission of HIV from injecting drug users to their wives in India. Int J STD AIDS. 2000;11:468-73.
7. Uusküla A, McMahon MJ, Kals M, Talu A, Abel-Ollo K, Rüütel K, Jarlais DC. Risk for heterosexual HIV transmission among non-injecting female partners of injection drug users in Estonia. AIDS Behav. 2011. doi: 10.1007/s10461-011-0078-9.
8. Latkin C, Srikrishnan A, Yang C, Johnson S, Solomon S, Kumar S, et al. The relationship between drug use stigma and HIV injection risk behaviors among injection drug users in Chennai, India. Drug Alcohol Depend. 2010;110(3):221-7.
9. NACO. National Behaviour Surveillance Survey. Delhi: National AIDS Control Organisation, Ministry of Health and Family Welfare, Government of India, 2006.
10. Solomon S, Srikrishnan A, Celentano D, Johnson S, Vasudevan C, Murugavel K, et al. The intersection between sex and drugs: a cross-sectional study among the spouses of injection drug users in Chennai, India. BMC Public Health. 2011;11(39):10.
11. Des Jarlais DC, Perlis T, Poznyak V. Characteristics of injecting drug users (IDUs) in different regions of the world: WHO Phase II Study. Paper presented at the international conference on the reduction of drug related harm, Melbourne;2004.
12. Des Jarlais DC, Semaan S. Interventions to reduce the sexual risk behaviour of injecting drug users. Int J Drug Policy. 2005;16S:S58-66.
13. Desenclos JC, Papaevangelou G, Ancelle-Park R. Knowledge of HIV serostatus and preventive behaviour among European injecting drug users. The European Community Study Group on HIV in Injecting Drug Users. AIDS. 1993;7(10):1371-7.
14. Vanichseni S, Choopanya K, Des Jarlais DC, Plangsringarm K, Sonchai W, Carballo M, et al. HIV testing and sexual behavior among intravenous drug users in Bangkok, Thailand. J Acquir Immune Defic Syndr. 1992;5(11):1119-23.
15. Grau LE, White E, Niccolai LM, Toussova OV, Verevochkin SV, Kozlov AP, Heimer R. HIV disclosure, condom use, and awareness of HIV infection among HIV-positive, heterosexual drug injectors in St. Petersburg, Russian Federation. AIDS Behav. 2011;15(1):45-7.
16. NACO. HIV sentinel surveillance and HIV estimation in India 2007. A technical brief. http://www.nacoonline.org/upload/Publication/ M&E%20Surveillance,%20Research/ HIV%20Sentinel%20Surveillance%20and%20HIV%20Estimation%202007- A%20Technical%20Brief (2007). Accessed 8 Sept 2012.
17. Baveja B, Chattopadhya D, Khera R, Joshi P. A cross sectional serological study of the co-infection of hepatitis B virus, hepatitis C virus and human immunodeficiency virus amongst a cohort of IDUs at Delhi. Indian J Med Microbiol. 2003;21(4):280-3.
18. Solomon SS, Celentano DD, Srikrishnan AK, Vasudevan CK, Murugavel KG, Iqbal SH, Anand S, Kumar MS, Latkin C, Solomon S, Mehta SH. Low incidences of human immunodeficiency virus and hepatitis C virus infection and declining risk behaviors in a cohort of injection drug users in Chennai, India. Am J Epidemiol. 2010;172(11):1259-67.
19. Solomon SS, Srikrishnan AK, Mehta SH, Vasudevan CK, Murugavel KG, Thamburaj E, Anand S, Kumar MS, Latkin C, Solomon S, Celentano DD. High prevalence of HIV, HIV/hepatitis C virus co-infection and risk behaviors among IDUs in Chennai, India: a cause for concern. J Acquir Immune Defic Syndr. 2008;49(3):327-32.
20. NACO. Operational guidelines for integrated counseling and testing centres. http://nacoonline.org/upload/Policies%20&%20Guidelines/20, %20Operational%20Guidelines%20for%20Integrated%20Counseling%20and%20Testing%20C entres (2007). Accessed 15 Sept 2012.
21. Behrens T, Taeger D, Wellmann J, Keil U. Different methods to calculate effect estimates in cross-sectional studies. A comparison between prevalence odds ratios and prevalence ratio. Methods Inf Med. 2004;43(5):505-9.
22. Zou G. A modified Poisson regression approach to prospective studies with binary data. Am J Epidemiol. 2004;159(7):702-6.
23. Cook T. Advanced statistics: up with odds ratios! A case for odds ratios when outcomes are common. Acad Emerg Med. 2002;9:1430-4.
24. Eicher A, Crofts N, Benjamin S, Deutschmann P, Rodger A. A certain fate: spread of HIV among young injecting drug users in Manipur, North-East India. AIDS CARE. 2000;12(4):497-504.
25. Buxton M, Vlahov D, Strathdee S, Jarlais DD, Morse E, Ouellet L, et al. Association between injection practices and duration of injection among recently initiated injection drug users. Drug Alcohol Depend. 2004;75(2):177-83.
26. Fennema J, Ameijden EV, Hoek AVD, Coutinho R. Young and recent-onset injecting drug users are at higher risk for HIV. Addiction. 1997;92:1457-65.
27. Razak MH, Jittiwutikarn J, Suriyanon V, Vongchak T, Srirak N, Beyrer C, et al. HIV prevalence and risks among injection and noninjection drug users in northern Thailand: need for comprehensive HIV prevention programs. J Acquir Immune Defic Syndr. 2003;33(2):259-66.
28. Vanichseni S, Kityaporn T, Maestro T. Continued high HIV-1 incidence in a vaccine preparatory trial cohort of injection drug users in Bangkok, Thailand. AIDS. 2001;15:397-405.
29. Corneil T, Kuyper L, Shoveller J, Hogg R, Li K, Spittal P, et al. Unstable housing, associated risk behaviour and increased risk for HIV infection among injection drug users. Health Place. 2006;12:78-85.
30. Jarlais DD, Braine N, Friedmann P. Unstable housing as a factor for increased injection risk behavior at US syringe exchange programs. AIDS Behav. 2007;1(6 Supplement):78-94.
31. Oetting ER, Beauvais F. Peer cluster theory: drugs and the adolescent. J Couns Dev. 1986;65(1):17-22.
32. Wattana W, van Griensven F, Rhucharoenpornpanich O, et al. Respondent driven sampling to assess characteristics and estimate the number of injection drug users in Bangkok, Thailand. Drug Alcohol Depend. 2007;90:228-33.
33. NACO. Targeted interventions under NACP III, Volume I: core high risk groups. http://www.nacoonline.org/upload/Publication/ NGOs%20and%20targetted%20Intervations/NACP-III.pdf (2007). Accessed 10 Oct 2012.
34. Samuels J, Vlahov D, Anthony J, Chaisson R. Measurement of HIV risk behaviors among intravenous drug users. Br J Addict. 1992;87(3):417-28.
35. Block J, Block JH, Keyes S. Longitudinally foretelling drug usage in adolescence: early childhood personality and environmental precursors. Child Dev. 1988;59(2):336-55.
36. Salganik M, Heckathorn D. Sampling and estimation in hidden populations using respondent-driven sampling. Soc Methodol. 2004;34:193-239.
37. Magnani R, Sabin K, Saidel T, Heckathorn D. Review of sampling hard-to-reach and hidden population for HIV surveillance. AIDS. 2005;19(Supplement 2):S67-72.